15 results
ARS
2023 FY
MYGN
Myriad Genetics, Inc.
17 Apr 24
Annual report to shareholders
4:33pm
proposed rule that would apply the existing medical device framework to laboratory-developed products may renew stakeholder calls for a more targeted … broader developments across the stakeholder community. In response to public letters from the national laboratory trade association and patient groups
ARS
2022 FY
MYGN
Myriad Genetics, Inc.
12 Apr 23
Annual report to shareholders
4:10pm
developments across the stakeholder community. In response to public letters from the national laboratory trade association and patient groups
10-KT
tsg6m9
16 Mar 21
Annual report (with FYE transition)
2:24pm
DEFA14A
zc8dk05hhuu
15 Oct 20
Additional proxy soliciting materials
7:20am
8-K
EX-99.1
40ljj9fcpcc0cb5
15 Oct 20
Myriad Genetics Files Fiscal Year 2020 Proxy Statement, Implements Corporate
7:18am
- Prev
- 1
- Next